You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Drug Price Trends for NDC 76329-3352


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 76329-3352

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
SODIUM BICARBONATE 84MG/ML INJ,SYRINGE,50ML Amphastar Pharmaceuticals, Inc. 76329-3352-01 10X50ML 117.49 2022-01-15 - 2027-01-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Sodium Bicarbonate Injection (NDC: 76329-3352)

Introduction

Sodium bicarbonate injections are crucial in various medical settings, including hospitals, specialty clinics, and recovery centers, for treating conditions such as metabolic acidosis and as an adjunct in severe diabetic ketoacidosis. Here, we will delve into the market analysis and price projections for sodium bicarbonate injection, specifically focusing on the product with NDC 76329-3352.

Market Overview

The global sodium bicarbonate injection market is experiencing significant growth driven by several key factors:

Increasing Demand in Healthcare

The COVID-19 pandemic has accelerated the demand for healthcare services, including the use of sodium bicarbonate injections. This increased demand is attributed to the rising cases of severe infections and the need for intensive care treatments[1].

Application Segments

Sodium bicarbonate injections are used in various healthcare settings:

  • Hospitals: The primary users, where these injections are administered for critical care.
  • Specialty Clinics: Used for outpatient treatments and follow-up care.
  • Recovery Centers: Essential for post-surgical care and rehabilitation[1].

Market Size and Growth

The global sodium bicarbonate injection market is projected to grow significantly over the forecast period (2021-2027). Here are some key metrics:

Revenue Growth

The market is expected to see substantial revenue growth, driven by increasing demand and expanding applications. The revenue is segmented by product concentration (0.042 and 0.084) and by application (hospital, specialty clinic, recovery center)[1].

Regional Analysis

The market is geographically segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America and Europe are expected to be major contributors due to advanced healthcare infrastructure and higher adoption rates[1].

Price Projections

Price projections for sodium bicarbonate injections are influenced by several factors:

Drug Price Inflation

According to Vizient's Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected at 3.81% for 2025. This inflation rate can impact the pricing of sodium bicarbonate injections[2].

Competitive Landscape

The market is competitive with several key players such as Amphastar, Exela Pharma Sciences, Fresenius Kabi, Long Grove Pharmaceuticals, and Pfizer. The competition can lead to price stability or slight increases, depending on market dynamics[1][5].

Supply Chain and Availability

Drug shortages can significantly impact pricing. For instance, Fresenius Kabi's 4.2% sodium bicarbonate 5 mL vials are currently on back order, which could lead to price fluctuations due to supply and demand imbalances[5].

Key Factors Influencing Pricing

Generic Drug Price Erosion

In the generic drug industry, mid-single-digit percent annual price erosion is expected. However, this may not significantly impact sodium bicarbonate injections, as they are often used in critical care and may not be as susceptible to price erosion[3].

FDA Regulations and Inspections

Potential increases in FDA inspections of foreign manufacturing facilities and price-fixing litigation could impact the pricing and availability of sodium bicarbonate injections[3].

Regional Price Variations

Prices of sodium bicarbonate injections vary significantly across different regions:

US vs. Global Prices

The average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is due to the higher prices for the same drugs in the U.S. and a drug mix that skews towards more expensive compounds[4].

Specific Product Analysis (NDC: 76329-3352)

The sodium bicarbonate injection with NDC 76329-3352, manufactured by Amphastar, is an 8.4% solution in a 50 mL syringe.

Current Market Status

This product is part of the competitive landscape where multiple manufacturers offer similar concentrations. The current market status, including any shortages or supply chain issues, can affect its pricing.

Price Projections

Given the overall drug price inflation rate and the specific market dynamics, the price of this product is likely to see a moderate increase. Here are some projections:

  • Short-term (2025): A 3-4% increase in price, aligning with the overall drug price inflation rate.
  • Medium-term (2025-2027): Prices may stabilize or see slight increases depending on supply chain stability and competitive pressures.

Conclusion

The market for sodium bicarbonate injections, including the product with NDC 76329-3352, is driven by increasing demand in healthcare settings and influenced by various market and regulatory factors. Price projections indicate moderate increases due to inflation and market dynamics.

Key Takeaways

  • Increasing Demand: Driven by COVID-19 and expanding healthcare services.
  • Regional Variations: Significant price differences between the U.S. and other regions.
  • Price Projections: Moderate increases expected due to inflation and market dynamics.
  • Supply Chain: Shortages and supply chain issues can impact pricing.
  • Regulatory Factors: FDA inspections and price-fixing litigation can influence pricing.

FAQs

  1. What is the current market size of the global sodium bicarbonate injection market?

    • The exact current market size is not specified, but it is projected to grow significantly over the forecast period (2021-2027)[1].
  2. Which regions are expected to be major contributors to the sodium bicarbonate injection market?

    • North America and Europe are expected to be major contributors due to advanced healthcare infrastructure and higher adoption rates[1].
  3. What is the projected drug price inflation rate for 2025?

    • The overall drug price inflation rate for pharmaceuticals is projected at 3.81% for 2025[2].
  4. How do regional prices of sodium bicarbonate injections compare?

    • Prices in the U.S. are significantly higher than in the OECD and the rest of the world[4].
  5. What factors could impact the pricing of sodium bicarbonate injections?

    • Supply chain issues, FDA regulations, and competitive pressures can impact pricing[1][3][5].

Sources

  1. Reports and Data: Sodium Bicarbonate Injection Market Size, Growth & Analysis, By Product (0.042, 0.084), By Application (Hospital, Speciality Clinic, Recovery Center), By Region, Forecasts to 2027.
  2. Vizient Inc.: Vizient projects drug price inflation at 3.81%.
  3. S&P Global: Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures.
  4. ASPE: International Market Size and Prices.
  5. ASHP: Drug Shortage Detail: Sodium Bicarbonate Injection.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.